Search

Your search keyword '"Colitis -- Drug therapy"' showing total 224 results
Start Over Descriptor "Colitis -- Drug therapy"
224 results on '"Colitis -- Drug therapy"'

1. Researchers at China Pharmaceutical University Target Colitis (Probiotics-loaded Selenium Nanoparticles Effectively Alleviated Dss-induced Colitis By Scavenging Ros and Remodeling Intestinal Innate Immune and Microbiota)

Subjects
Microbiota (Symbiotic organisms), Selenium, Colitis -- Drug therapy, Gastrointestinal diseases -- Drug therapy, Probiotics, Physical fitness, Health
Abstract

2024 SEP 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Digestive System Diseases and Conditions - Colitis. [...]

Published
2024

2. University Medical Centre Maribor Researcher Furthers Understanding of Colitis (Colitis due to cancer treatment with immune check-point inhibitors - review of literature and presentation of clinical cases)

Subjects
Oncology, Experimental, Medical centers, Colitis -- Drug therapy, Gastrointestinal system, Cancer -- Care and treatment -- Research, Physical fitness, Health
Abstract

2024 APR 13 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New study results on colitis have been published. According to news reporting [...]

Published
2024

3. Studies from Tianjin University Describe New Findings in Colitis (OP26 Programmable probiotic local delivery of anti-TNF-a nanobody to alleviate DSS-induced colitis)

Subjects
Drugs -- Vehicles, Colitis -- Drug therapy, Tumor necrosis factor inhibitors -- Dosage and administration, Drug delivery systems -- Innovations -- Physiological aspects, Probiotics -- Usage -- Health aspects -- Physiological aspects, Health
Abstract

2024 FEB 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators discuss new findings in colitis. According to news reporting originating from [...]

Published
2024

4. Researcher at Faculty of Medicine Targets Colitis (Circadian Rhythm Perturbation Aggravates Gut Microbiota Dysbiosis in Dextran Sulfate Sodium-Induced Colitis in Mice)

Subjects
Dextran -- Analysis -- Reports, Microbiota (Symbiotic organisms) -- Reports -- Analysis, Colitis -- Drug therapy, Sulfates -- Analysis -- Reports, Gastrointestinal diseases -- Drug therapy, Physical fitness -- Analysis -- Reports, Health
Abstract

2024 FEB 3 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on colitis is now available. According to news reporting [...]

Published
2024

5. Investigators from Fujian Medical University Release New Data on Esophageal Cancer (Fecal Microbiota Transplantation Alleviates Severe Pd-1 Inhibitor-associated Colitis Caused By Neoadjuvant Therapy for Esophageal Cancer)

Subjects
Microbiota (Symbiotic organisms) -- Health aspects, Cancer -- Adjuvant treatment, Neoadjuvant therapy -- Health aspects, Colitis -- Drug therapy, Palladium -- Health aspects, Esophageal cancer -- Drug therapy, Business, Health, Health care industry
Abstract

2024 OCT 29 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Current study results on Oncology - Esophageal Cancer have been published. According to news reporting [...]

Published
2024

6. Reports Outline Inflammatory Bowel Disease Study Findings from Henan Luoyang Orthopedic Hospital (Modified Montmorillonite Armed Probiotics With Enhanced On-site Mucus-depleted Intestinal Colonization and H2s 2 S Scavenging for Colitis Treatment)

Subjects
Medical research, Medicine, Experimental, Microbiota (Symbiotic organisms), Montmorillonite, Colitis -- Drug therapy, Hydrogen sulfide, Gastrointestinal diseases -- Drug therapy, Probiotics, Clay, Health
Abstract

2024 OCT 11 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Data detailed on Digestive System Diseases and Conditions - Inflammatory Bowel Disease have [...]

Published
2024

7. Research on Crohn's Disease and Colitis Detailed by a Researcher at Icahn School of Medicine at Mount Sinai (Etrasimod Corticosteroid-Free Efficacy, Impact of Concomitant Corticosteroids on Efficacy and Safety, and Corticosteroid-Sparing Effect ...)

Subjects
Medical research, Medicine, Experimental, Corticosteroids, Diseases -- Drug therapy, Colitis -- Drug therapy, Medical colleges
Abstract

2024 OCT 7 (NewsRx) -- By a News Reporter-Staff News Editor at Gastroenterology Week -- New study results on Crohn's disease and colitis have been published. According to news reporting [...]

Published
2024

10. U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO[R] (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn's Disease

Subjects
United States. Food and Drug Administration, Takeda Pharmaceutical Company Ltd., Colitis -- Drug therapy, Financial statements, Pharmaceutical industry, Business, Business, international
Abstract

ENTYVIO is Now Available in the U.S. in Both IV and Subcutaneous Administrations for Maintenance Treatment of Adults with Moderately to Severely Active Ulcerative Colitis or Crohn's Disease OSAKA, Japan [...]

Published
2024

11. Data from National Taiwan University Hospital and School of Medicine Broaden Understanding of Colitis (Transepithelial barrier dysfunction drives microbiota dysbiosis to initiate epithelial clock-driven inflammation)

Subjects
Microbiota (Symbiotic organisms), Myosin, Inflammation -- Drug therapy, Colitis -- Drug therapy, Genetic polymorphisms, Gastrointestinal diseases -- Drug therapy, Physical fitness, Health
Abstract

2023 APR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in colitis. According to news reporting originating from [...]

Published
2023

12. CENTRALA FARMACEUTYCZNA CEFARM S.A. secures contract for Pharmaceutical products - Delivery of drugs used in drug programs - hepatitis B and C, SM, ulcerative colitis and Crohn, migraine and others

Subjects
Migraine -- Drug therapy, Colitis -- Drug therapy, Hepatitis B -- Drug therapy, Contract agreement, News, opinion and commentary
Abstract

Poland based CENTRALA FARMACEUTYCZNA CEFARM S.A. has secured contract from Wojewodzki Szpital Specjalistyczny im. J. Gromkowskiego for Pharmaceutical products - Delivery of drugs used in drug programs - hepatitis B [...]

Published
2023

13. JANSSEN-CILAG POLSKA SP. Z O.O. secures contract for Pharmaceutical products - Delivery of drugs used in drug programs - hepatitis B and C, SM, ulcerative colitis and Crohn, migraine and others

Subjects
Migraine -- Drug therapy, Colitis -- Drug therapy, Hepatitis B -- Drug therapy, Contract agreement, News, opinion and commentary
Abstract

Poland based JANSSEN-CILAG POLSKA SP. Z O.O. has secured contract from Wojewodzki Szpital Specjalistyczny im. J. Gromkowskiego for Pharmaceutical products - Delivery of drugs used in drug programs - hepatitis [...]

Published
2023

14. FARMACOL LOGISTYKA SP. Z O.O. secures contract for Pharmaceutical products - Delivery of drugs used in drug programs - hepatitis B and C, SM, ulcerative colitis and Crohn, migraine and others

Subjects
Migraine -- Drug therapy, Colitis -- Drug therapy, Hepatitis B -- Drug therapy, Contract agreement, News, opinion and commentary
Abstract

Poland based FARMACOL LOGISTYKA SP. Z O.O. has secured contract from Wojewodzki Szpital Specjalistyczny im. J. Gromkowskiego for Pharmaceutical products - Delivery of drugs used in drug programs - hepatitis [...]

Published
2023

15. ASCLEPIOS S.A. secures contract for Pharmaceutical products - Delivery of drugs used in drug programs - hepatitis B and C, SM, ulcerative colitis and Crohn, migraine and others

Subjects
Migraine -- Drug therapy, Colitis -- Drug therapy, Hepatitis B -- Drug therapy, Contract agreement, News, opinion and commentary
Abstract

Poland based ASCLEPIOS S.A. has secured contract from Wojewodzki Szpital Specjalistyczny im. J. Gromkowskiego for Pharmaceutical products - Delivery of drugs used in drug programs - hepatitis B and C, [...]

Published
2023

16. URTICA SP. Z O.O. secures contract for Pharmaceutical products - Delivery of drugs used in drug programs - hepatitis B and C, SM, ulcerative colitis and Crohn, migraine and others

Subjects
Migraine -- Drug therapy, Colitis -- Drug therapy, Hepatitis B -- Drug therapy, Contract agreement, News, opinion and commentary
Abstract

Poland based URTICA SP. Z O.O. has secured contract from Wojewodzki Szpital Specjalistyczny im. J. Gromkowskiego for Pharmaceutical products - Delivery of drugs used in drug programs - hepatitis B [...]

Published
2023

17. TAKEDA PHARMA SP. Z O.O. secures contract for Pharmaceutical products - Delivery of drugs used in drug programs - hepatitis B and C, SM, ulcerative colitis and Crohn, migraine and others

Subjects
Migraine -- Drug therapy, Colitis -- Drug therapy, Hepatitis B -- Drug therapy, Contract agreement, News, opinion and commentary
Abstract

Poland based TAKEDA PHARMA SP. Z O.O. has secured contract from Wojewodzki Szpital Specjalistyczny im. J. Gromkowskiego for Pharmaceutical products - Delivery of drugs used in drug programs - hepatitis [...]

Published
2023

18. NEUCA SPolKA AKCYJNA secures contract for Pharmaceutical products - Delivery of drugs used in drug programs - hepatitis B and C, SM, ulcerative colitis and Crohn, migraine and others

Subjects
Migraine -- Drug therapy, Colitis -- Drug therapy, Hepatitis B -- Drug therapy, Contract agreement, News, opinion and commentary
Abstract

Poland based NEUCA SPolKA AKCYJNA has secured contract from Wojewodzki Szpital Specjalistyczny im. J. Gromkowskiego for Pharmaceutical products - Delivery of drugs used in drug programs - hepatitis B and [...]

Published
2023

19. ROCHE POLSKA SP. Z O.O. secures contract for Pharmaceutical products - Delivery of drugs used in drug programs - hepatitis B and C, SM, ulcerative colitis and Crohn, migraine and others

Subjects
Migraine -- Drug therapy, Colitis -- Drug therapy, Hepatitis B -- Drug therapy, Contract agreement, News, opinion and commentary
Abstract

Poland based ROCHE POLSKA SP. Z O.O. has secured contract from Wojewodzki Szpital Specjalistyczny im. J. Gromkowskiego for Pharmaceutical products - Delivery of drugs used in drug programs - hepatitis [...]

Published
2023

20. ABBVIE SP. Z O.O. secures contract for Pharmaceutical products - Delivery of drugs used in drug programs - hepatitis B and C, SM, ulcerative colitis and Crohn, migraine and others

Subjects
Migraine -- Drug therapy, Colitis -- Drug therapy, Hepatitis B -- Drug therapy, Contract agreement, News, opinion and commentary
Abstract

Poland based ABBVIE SP. Z O.O. has secured contract from Wojewodzki Szpital Specjalistyczny im. J. Gromkowskiego for Pharmaceutical products - Delivery of drugs used in drug programs - hepatitis B [...]

Published
2023

21. Ocean University of China Researchers Advance Knowledge in Colitis (Comparative Pharmacokinetics and Tissue Distribution of M10 and Its Metabolite Myricetin in Normal and Dextran-Sodium-Sulfate-Induced Colitis Mice)

Subjects
Dextran -- Comparative analysis, Colitis -- Drug therapy, Metabolites -- Comparative analysis, Sulfates -- Comparative analysis, Physical fitness -- Comparative analysis, Health
Abstract

2022 DEC 31 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on colitis. According to news originating from Qingdao, [...]

Published
2022

22. Reports from King Abdulaziz University Add New Study Findings to Research in Colitis (Olmesartan medoxomil self-microemulsifying drug delivery system reverses apoptosis and improves cell adhesion in trinitrobenzene sulfonic acid-induced colitis ...)

Subjects
Colitis -- Drug therapy, Health
Abstract

2022 DEC 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on colitis have been presented. According to news reporting originating [...]

Published
2022

23. Studies from Nanjing Medical University Update Current Data on Colitis (Alpha 7 Nicotinic Acetylcholine Receptor Agonist Gts-21 Attenuates Dss-induced Intestinal Colitis By Improving Intestinal Mucosal Barrier Function)

Subjects
Intestinal mucosa -- Testing, Colitis -- Drug therapy, Cholinesterase inhibitors -- Testing, Health
Abstract

2022 DEC 10 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Digestive System Diseases and Conditions - Colitis. [...]

Published
2022

24. Why cancer immunotherapy can cause colitis

Subjects
Colitis -- Drug therapy, Immunotherapy -- Health aspects, Cancer -- Care and treatment -- Drug therapy, University of Michigan
Abstract

Researchers have identified a mechanism that causes severe gastrointestinal problems with immune-based cancer treatment. They also found a way to deliver immunotherapy's cancer-killing impact without the unwelcome side effect. 'This [...]

Published
2024

25. Data from Shenzhen University School of Medicine Advance Knowledge in Colitis (Munronoid I Ameliorates DSS-Induced Mouse Colitis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Via Modulation of NLRP3)

Subjects
Colitis -- Drug therapy, Gastrointestinal system, Gastrointestinal diseases -- Drug therapy, Physical fitness, Health
Abstract

2022 JUL 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in colitis. According to news reporting from Shenzhen, [...]

Published
2022

26. TAKEDA PHARMA Sp. z o.o. secures contract for Pharmaceutical products - 'Successive delivery of drugs used in drug programs: - B55 - treatment of patients with ulcerative colitis - B32 - treatment of Lesniow - Crohn's disease'

Subjects
Colitis -- Drug therapy, Contract agreement, News, opinion and commentary
Abstract

Poland based TAKEDA PHARMA Sp. z o.o. has secured contract from Samodzielny Publiczny Zaklad Opieki Zdrowotnej w Miedzychodzie for Pharmaceutical products - 'Successive delivery of drugs used in drug programs: [...]

Published
2023

27. JANSSEN-CILAG POLSKA Sp. z o.o. secures contract for Pharmaceutical products - 'Successive delivery of drugs used in drug programs: - B55 - treatment of patients with ulcerative colitis - B32 - treatment of Lesniow - Crohn's disease'

Subjects
Colitis -- Drug therapy, Contract agreement, News, opinion and commentary
Abstract

Poland based JANSSEN-CILAG POLSKA Sp. z o.o. has secured contract from Samodzielny Publiczny Zaklad Opieki Zdrowotnej w Miedzychodzie for Pharmaceutical products - 'Successive delivery of drugs used in drug programs: [...]

Published
2023

28. FARMACOL-LOGISTYKA Sp. z o.o. secures contract for Pharmaceutical products - 'Successive delivery of drugs used in drug programs: - B55 - treatment of patients with ulcerative colitis - B32 - treatment of Lesniow - Crohn's disease'

Subjects
Colitis -- Drug therapy, Contract agreement, News, opinion and commentary
Abstract

Poland based FARMACOL-LOGISTYKA Sp. z o.o. has secured contract from Samodzielny Publiczny Zaklad Opieki Zdrowotnej w Miedzychodzie for Pharmaceutical products - 'Successive delivery of drugs used in drug programs: - [...]

Published
2023

29. URTICA Sp. z o.o. secures contract for Pharmaceutical products - 'Successive delivery of drugs used in drug programs: - B55 - treatment of patients with ulcerative colitis - B32 - treatment of Lesniow - Crohn's disease'

Subjects
Colitis -- Drug therapy, Contract agreement, News, opinion and commentary
Abstract

Poland based URTICA Sp. z o.o. has secured contract from Samodzielny Publiczny Zaklad Opieki Zdrowotnej w Miedzychodzie for Pharmaceutical products - 'Successive delivery of drugs used in drug programs: - [...]

Published
2023

30. PFIZER TRADING POLSKA Sp. z o.o. secures contract for Pharmaceutical products - 'Successive delivery of drugs used in drug programs: - B55 - treatment of patients with ulcerative colitis - B32 - treatment of Lesniow - Crohn's disease'

Subjects
Pfizer Inc. -- Contracts, Colitis -- Drug therapy, Pharmaceutical industry -- Contracts, Contract agreement, News, opinion and commentary
Abstract

Poland based PFIZER TRADING POLSKA Sp. z o.o. has secured contract from Samodzielny Publiczny Zaklad Opieki Zdrowotnej w Miedzychodzie for Pharmaceutical products - 'Successive delivery of drugs used in drug [...]

Published
2023

31. ASCLEPIOS secures contract for Pharmaceutical products - 'Successive delivery of drugs used in drug programs: - B55 - treatment of patients with ulcerative colitis - B32 - treatment of Lesniow - Crohn's disease'

Subjects
Colitis -- Drug therapy, Contract agreement, News, opinion and commentary
Abstract

Poland based ASCLEPIOS has secured contract from Samodzielny Publiczny Zaklad Opieki Zdrowotnej w Miedzychodzie for Pharmaceutical products - 'Successive delivery of drugs used in drug programs: - B55 - treatment [...]

Published
2023

32. Reports from University Hospital Mutua Terrassa Describe Recent Advances in Crohn's Disease [Position Statement. Recommendations of the Spanish Group On Crohn's Disease and Ulcerative Colitis (Geteccu) On the Treatment of Strictures In Crohn's ...]

Subjects
Medical research -- Health aspects -- Reports, Medicine, Experimental -- Health aspects -- Reports, Colitis -- Drug therapy, Gastrointestinal diseases -- Drug therapy, Physical fitness -- Health aspects -- Reports, Health
Abstract

2022 MAY 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on Digestive System Diseases and Conditions - Crohn's Disease are [...]

Published
2022

33. Data from Hong Kong Polytechnic University Advance Knowledge in Inflammatory Bowel Disease (Beneficial and Anti-inflammatory Effects of Formulated Prebiotics, Probiotics, and Synbiotics In Normal and Acute Colitis Mice)

Subjects
Microbiota (Symbiotic organisms) -- Analysis, Colitis -- Drug therapy, Anti-inflammatory drugs -- Analysis, Gastrointestinal diseases -- Drug therapy, Probiotics -- Analysis, Physical fitness -- Analysis, Health
Abstract

2022 JAN 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Digestive System Diseases and Conditions - Inflammatory [...]

Published
2022

34. US FDA approves RINVOQ (upadacitinib) as a once-daily pill for moderately to severely active Crohn's disease in adults

Subjects
United States. Food and Drug Administration, AbbVie Inc., Colitis -- Drug therapy, Drug approval, Adults, Business, Chemicals, plastics and rubber industries, Rinvoq (Medication)
Abstract

AbbVie announced on 18 May 2023 that the US Food and Drug Administration (FDA) has approved RINVOQ (upadacitinib) for the treatment of adults with moderately to severely active Crohn's disease who have had an inadequate response or intolerance to one or more TNF blockers. This is the seventh FDA approval for RINVOQ across rheumatology, dermatology, and gastroenterology, where it is now indicated in both ulcerative colitis and Crohn's disease. The approval is supported by data from two induction studies, U-EXCEED and U-EXCEL, and the U-ENDURE maintenance study. Statistical significance was achieved for the co-primary endpoints and key secondary endpoints with RINVOQ 45 mg in the induction studies and RINVOQ 15 mg and 30 mg in the maintenance study compared to placebo. Endoscopic response: In the two induction studies, 34% and 46% of patients treated with RINVOQ 45 mg achieved endoscopic response (defined as a decrease of greater than 50% from the baseline Simplified Endoscopic Score for CD [SES-CD] or for patients with isolated ileal disease and a baseline SES-CD of 4, at least a 2-point reduction from baseline) at week 12, respectively, compared to 3% and 13% of patients receiving placebo. In the maintenance study, 28% and 41% of patients treated with RINVOQ 15 mg and 30 mg achieved endoscopic response at week 52, respectively, compared to 7% of patients receiving placebo. Clinical remission: In the two induction studies, 36% and 46% of patients treated with RINVOQ 45 mg achieved clinical remission [defined as a Crohn's Disease Activity Index (CDAI) of less than 150] at 12 weeks, respectively, compared to 18% and 23% of patients receiving placebo. Additionally, in the maintenance trial, 42% and 55% of patients treated with RINVOQ 15 mg and 30 mg achieved clinical remission at 52 weeks, respectively, compared to 14% of patients receiving placebo. Onset of clinical response based on CDAI was observed as early as two weeks in U-EXCEED and U-EXCEL, with a greater proportion of patients achieving clinical response at week 2 in RINVOQ-treated patients compared with placebo. This is the first clinical programme of an approved moderate-to-severe Crohn's disease treatment to require steroid taper during the induction period, with a corticosteroid taper regimen initiated at week 4. Corticosteroid-free clinical remission [defined as discontinuation of steroid and achievement of clinical remission per CDAI (CDAI less than 150)] among patients on steroid at baseline was achieved at week 12 by more patients treated with RINVOQ in U-EXCEED and U-EXCEL (30% and 40%, respectively) compared to placebo (11% and 13%, respectively). In U-ENDURE, corticosteroid-free remission (defined as no corticosteroids for 90 days prior to week 52 and achievement of clinical remission) was achieved by more patients treated with RINVOQ 15 mg and 30 mg (42% and 53%, respectively) compared to 14% with placebo. Original source: Abbvie, website: https://www.abbvie.com/, Copyright Abbvie Inc. 2023., regulations and rulings; research and development; Crohn's disease treatments; RINVOQ; upadacitinib; [...]

Published
2023

35. Josep Bassaganya-Riera Launches NImmune Biopharma with Phase 3-Ready Clinical Candidate Omilancor for the Treatment of Ulcerative Colitis and Crohn's Disease

Subjects
Biological products industry, Colitis -- Drug therapy, Business, Business, international
Abstract

-- Led by Dr. Bassaganya-Riera and a team of seasoned industry executives, NImmune is developing later-stage precision therapies addressing multiple autoimmune diseases, starting with Ulcerative Colitis (UC) and Crohn's disease [...]

Published
2023

36. New Findings from University of Texas Health Science Center Houston in the Area of Colitis Reported [Anti-cd20 Monoclonal Antibody (Mab) Therapy and Colitis: a Case Series and Review]

Subjects
United States. Food and Drug Administration -- Reports, Medical research -- Reports, Medicine, Experimental -- Reports, Biopharmaceutics -- Reports, Multiple sclerosis -- Drug therapy, Colitis -- Drug therapy, Immunotherapy -- Reports, Drug approval -- Reports, Gastrointestinal diseases -- Drug therapy, Health
Abstract

2023 JUL 26 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- A new study on Digestive System Diseases and Conditions - Colitis is now available. According [...]

Published
2023

37. Radboud University Medical Center Researchers Have Published New Data on Colitis (Case Report: A severe case of immunosuppressant-refractory immune checkpoint inhibitor-mediated colitis rescued by tofacitinib)

Subjects
Medical centers, Ipilimumab, Tofacitinib, Colitis -- Drug therapy, Immunotherapy, Immunosuppressive agents, Melanoma -- Drug therapy, Health
Abstract

2023 JUL 12 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Fresh data on colitis are presented in a new report. According to news originating from [...]

Published
2023

38. New Colitis Data Have Been Reported by Researchers at University of Shizuoka (Tranilast-loaded Amorphous Solid Dispersion Prepared With Fine Droplet Drying Process for Improvement of Oral Absorption and Anti-inflammatory Effects On ...)

Subjects
Colitis -- Drug therapy, Anti-inflammatory drugs, Gastrointestinal diseases -- Drug therapy, Physical fitness, Health
Abstract

2021 AUG 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Digestive System Diseases and Conditions - Colitis. [...]

Published
2021

40. Researchers at Tongji University Release New Data on Colitis (Whole intestinal microbiota transplantation is more effective than fecal microbiota transplantation in reducing the susceptibility of DSS-induced germ-free mice colitis)

Subjects
Medical research, Medicine, Experimental, Microbiota (Symbiotic organisms), Colitis -- Drug therapy, Gastrointestinal diseases -- Drug therapy, Health
Abstract

2023 MAY 26 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Researchers detail new data in colitis. According to news reporting originating from Shanghai, [...]

Published
2023

41. Data from China Pharmaceutical University Advance Knowledge in Colitis (Development of Novel Tetrahydroquinoline Inhibitors of NLRP3 Inflammasome for Potential Treatment of DSS-Induced Mouse Colitis)

Subjects
Colitis -- Drug therapy, Gastrointestinal diseases -- Drug therapy, Physical fitness, Health
Abstract

2021 JAN 9 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Digestive System Diseases and Conditions - Colitis have been [...]

Published
2021

42. New Colitis Study Results Reported from Institute of Biomedical Sciences (Treatment of murine colitis by Saccharomyces boulardii secreting atrial natriuretic peptide)

Subjects
Physical fitness, Gastrointestinal diseases -- Drug therapy, Natriuretic peptides, Colitis -- Drug therapy, Health
Abstract

2020 OCT 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Digestive System Diseases and Conditions - Colitis have [...]

Published
2020

43. Data on Ischemic Colitis Described by Researchers at Huazhong University of Science and Technology (Diagnostic methods and drug therapies in patients with ischemic colitis)

Subjects
Physical fitness -- Reports -- Analysis -- Methods, Gastrointestinal diseases -- Drug therapy, Colitis -- Drug therapy, Health
Abstract

2020 OCT 3 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on Digestive System Diseases and Conditions - Ischemic [...]

Published
2020

44. Data from Seoul National University College of Medicine Provide New Insights into Colitis (Soluble Siglec-9 alleviates intestinal inflammation through inhibition of the NF-kB pathway)

Subjects
Elsevier Science B.V., Periodical publishing, Physical fitness, Inflammation -- Drug therapy, Medical research, Gastrointestinal diseases -- Drug therapy, Colitis -- Drug therapy, Health
Abstract

2020 JUL 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Digestive System Diseases and Conditions - Colitis have [...]

Published
2020

45. Data from University of Illinois College of Medicine Advance Knowledge in Colitis [Wuchereria bancrofti macrophage migration inhibitory factor-2 (rWbaMIF-2) ameliorates experimental colitis]

Subjects
Macrophages, Physical fitness, Gastrointestinal diseases -- Drug therapy, Colitis -- Drug therapy, Inflammation, Anopheles, Dextrans, Medical research, Diseases, Obesity, Digestive system diseases, Sulfates, Autoimmune diseases, Editors, Polysaccharides, Novels, Health
Abstract

2020 FEB 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Digestive System Diseases and Conditions - Colitis have [...]

Published
2020

46. Study Data from University of Glasgow Update Understanding of Crohn's Disease and Colitis (DOP52 The faecal bacterial and fungal microbiome of newly-diagnosed, treatment naive children with Crohn's disease and the modifying effects of exclusive ...)

Subjects
Medical research, Medicine, Experimental, Pediatrics, Colitis -- Drug therapy, Health, University of Glasgow
Abstract

2023 FEB 17 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on Crohn's disease and colitis is now available. According to [...]

Published
2023

47. Reports from Dalian Polytechnic University Highlight Recent Findings in Colitis (Dual Targeting Procyanidin Nanoparticles With Glutathione Response for Colitis Treatment)

Subjects
Hyaluronic acid, Medical research, Medicine, Experimental, Nanoparticles, Colitis -- Drug therapy, Fatty acids, Thiols, Gastrointestinal diseases -- Drug therapy, Health
Abstract

2023 FEB 13 (NewsRx) -- By a News Reporter-Staff News Editor at Gastroenterology Week -- Investigators discuss new findings in Digestive System Diseases and Conditions - Colitis. According to news [...]

Published
2023

48. Jeonju AgroBio-Materials Institute Researchers Release New Data on Colitis (Anti-inflammatory effect and signaling mechanism of 8-shogaol and 10-shogaol in a dextran sodium sulfate-induced colitis mouse model)

Subjects
Dextran -- Physiological aspects, Medicine, Ayurvedic -- Physiological aspects, Colitis -- Drug therapy, Anti-inflammatory drugs -- Physiological aspects, Sulfates -- Physiological aspects, Hypertension -- Drug therapy, Health
Abstract

2023 FEB 3 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Data detailed on colitis have been presented. According to news originating from Jeonju, [...]

Published
2023

49. Weifang Medical University Researchers Update Knowledge of Colitis (Efficacy and Mechanism of Quercetin in the Treatment of Experimental Colitis Using Network Pharmacology Analysis)

Subjects
Bioflavonoids -- Analysis, Flavones -- Analysis, Colitis -- Drug therapy, Flavonoids -- Analysis, Health
Abstract

2023 JAN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on colitis. According to news reporting originating from Weifang, [...]

Published
2023

50. Studies from Mashhad University of Medical Sciences Add New Findings in the Area of Colitis (Sulfasalazine colon-specific drug delivery by selenium nanoparticle)

Subjects
Drugs -- Vehicles, Selenium -- Reports -- Analysis, Colitis -- Drug therapy, Sulfasalazine -- Reports -- Analysis, Drug delivery systems -- Analysis -- Reports, Health
Abstract

2022 DEC 30 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on colitis is now available. According to news originating from [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results